ReviewCurrent treatment options in oncology2019

Malignant Pleural Mesothelioma: Is Tailoring the Second-Line Therapy Really "Raising the Bar?"

Vincenzo Di Noia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.